Biotech

SC's decision to close criminal proceedings against the Sandesara brothers after a substantial repayment has raised concerns that other high-profile economic offenders may seek similar settlements

Kiran Mazumdar-Shaw urges India to achieve 'biotech sovereignty' by 2047, driven by a $330 bn bioeconomy, BioE3 framework, scale exports, a sovereign AI stack, and crucial R&D investment

As regulators ease biosimilar trial norms, Syngene International is expanding into late-stage clinical supply production, betting on biologics and peptide manufacturing for growth

In-space manufacturing uses the near-weightless environment of space to produce materials and products of superior quality

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough designations as they gain confidence in China's biotech innovation

Hyderabad-based biotech Utopia Therapeutics raises seed funding from Whale Tank to accelerate preclinical work on its novel immunotherapy vaccine targeting obesity

Lilly has struck multiple partnership deals with gene-editing companies in the last two years to expand its portfolio beyond its blockbuster weight-loss and diabetes drugs

The investment is expected to promote innovation and growth, further positioning Telangana as a global hub for emerging industries

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets

The Karnataka government and the German state of Bavaria signed a Memorandum of Understanding (MoU) on Tuesday to collaborate in key areas, including Artificial Intelligence, quantum technology, biotechnology, Smart Cities, higher education, and sustainable agriculture, among others. The MoU was signed by Karnataka's Minister for Large and Medium Industries, M B Patil, and Dr Florian Herrmann, Head of the Bavarian State Chancellery. Karnataka's Minister for IT/BT, Priyank Kharge, was also present at the event. Speaking on the occasion, Minister Patil stated that the agreement will remain in effect for five years. As part of the collaboration, the two regions will work together in sectors such as Industry 4.0, space technology, medical technology, green tech, urban infrastructure, skill development, employment generation, entrepreneurship, and cybersecurity, he added. During the meeting, Herrmann was briefed in detail about Karnataka's robust industrial ecosystem and the various ..

According to the report, titled "India Bioeconomy Report 2025", the bioeconomy sector witnessed a 16-fold expansion in the past decade, from $10 billion in 2014 to $165.7 billion in 2024

This initiative reinforces the company's mission to provide deep life sciences-backed, innovative shrimp and fish health and farm care solutions

The Genome India Data, which captures the genetic diversity of India's population, will be available to researchers at the Indian Biological Data Centre (IBDC) through managed access

The scheme aims to refund to exporters the embedded central, state, and local duties and taxes paid on inputs that were so far not refunded or rebated

It is targeting a $100 m inventory improvement by March

Chinese biomedical research is on the cusp of a breakthrough just as the industry starts to face serious headwinds

India's biotechnology sector is witnessing remarkable growth, with the country's bioeconomy now valued at USD 150 billion but there is still significant untapped potential in innovation and product development, which could further elevate India's global standing in the sector, Dr Jitendra Kumar, Managing Director of the government's Biotechnology Industry Research Assistance Council (BIRAC), said. BIRAC is a not-for-profit public sector enterprise set up by the Department of Biotechnology (DBT) under the government that supports and promotes innovation, entrepreneurship, and research in the sector. In an interview with PTI, Kumar highlighted India's significant contributions to global healthcare, with 40 per cent of the world's generic medicines being supplied by Indian companies. "We have enormous potential and capability, but when it comes to the value of our bioeconomy, we are ranked 14th globally. This is because much of the value stems from patented, innovative products' -- an

Startup founded in 2016 say it will use the investment for crop protection research, products

The Biosecure Act would restrict federally funded medical providers from contracting with a select group of Chinese biotech companies